join the leaders in advanced anti-aging medicine
Educational grant provided by Ananda
This 3-day certification program is designed to educate healthcare practitioners—both the novices and regular prescribers – on a variety of related topics based on the latest scientific evidence and clinical research. Primary topics incorporated throughout the program will include the major phytocannabinoids, cannabidiol (CBD), and delta-9-tetrahydrocannabinol (Δ9-THC) found in marijuana and hemp plants.
Topics
Cannabidiol (CBD) Applications
Endocannabinoid Overview
(discovery, mechanism of action, endo- and phytocannabinoids)
Psychological Disorders
Best Practices in Patient Evaluation
Inflammatory, Pain, and Metabolic Disorders
Anxiety or Insomnia
Head Trauma
Cancer
Legal, Regulatory, and Dosing
Neurological Disorders
Safety Considerations
(drug interactions, adverse events, and addiction)
Program Chair
Alex Capano,
DNP, CRNP, FNP-BC
Alex Capano, DNP, CRNP, FNP-BC, is the Chief Science Officer of Ecofibre Limited, the global leader in hemp technologies that provides innovation solutions to address emerging health and resource sustainability issues.
At Ecofibre, Dr. Capano champions the company’s $40 million commitment to research to advance the clinical evidence of hemp extract. Ecofibre was the first hemp company to receive IND authorization from the FDA for research. Partnering with leading healthcare and academic institutions, Dr. Capano is currently researching CBD’s effects on CIPN, sleep, anxiety, addiction, endometriosis, certain cancers, and cognitive decline.
Schedule
Registration
Certification Program